Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99–02). An open-label phase 3 randomised trial - Bourhis, J; Sire, C; Graff, P (The Lancet Oncology, 2012)
et al.